NIH 3T3 cell lines with various hepatocyte growth factor receptor or MET mutations using murine constructs.
MET or hepatocyte growth factor receptor (HGFR) is a protein involved in tyrosine kinase activity. MET is a single pass tyrosine kinase receptor that is essential for embryonic development, organogenesis and wound healing.
From the laboratory of Laura S. Schmidt, PhD, National Cancer Institute/NIH.
This product is for sale to Nonprofit customers only. For profit customers, please Contact Us for more information.
|Product Type:||Cell Line|
|Name:||Named based on human MET mutation|
|Cell Type:||Wild-type murine MET and murine MET mutations (based on human nomenclature) V1206L, V1110I, H1112Y, H1112L, H1124D, M1149T, L1213V, V1238I, Y1248H, Y1248D, M1268T in NIH3T3 cells|
|Source:||Embryo/established with stable transfection of mutant murine MET constructs into NIH3T3 cells with G418 selection|
|Growth Conditions:||DMEM, 10%FBS, 1% glutamine, 500 ug/ml G418 (Geneticin)|
|Cryopreservation:||DMEM, 25%FBS, 10% DMSO (v/v), 500 ug/ml G418|
NOTE: These cell lines have not been sequence verified since 1997 and it is recommended that purchasing investigators should do so before beginning experiments.